ARGENTINE HEMORRHAGIC FEVER


Cite item

Full Text

Abstract

Features of the Argentine hemorrhagic fever
are described in the review. Epidemiology, etiology,
clinical presentation and pathogenesis of
the disease are examined. Special consideration
is given to the features of the pathological agent
of Argentine hemorrhagic fever - the Junin
virus. Features of the disease diagnostics are
indicated - virological and serological studies,
immunochemical and molecular-biological
methods of identification of the pathological
agent and antibodies against it. Approaches to
etiotropic therapy of this disease and vaccination
are examined. Based on the foreign experience
perspective guidance for the creation of the
system of protection of the population of the
Russian Federation against Argentine hemorrhagic
fever are presented.

About the authors

V A Markin

V B Pantyukhov

V I Markov

V P Bondarev

V A Markin

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

V B Pantyukhov

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

V I Markov

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

V P Bondarev

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

Branch of 48th Central Research Institute ofMinistry of Defence of Russian Federation -Virology Centre, Sergiev Posad, Russia

References

  1. Виссенбах М.С., Гуэрро Л.Б., Боксак М.К. Экспериментальная биология и патогенез инфекции, вызываемой вирусом Хунин у животных и человека. Бюлл. ВОЗ. 1978, 52: 500-508.
  2. Маркин В.А., Марков В.И. Вирусные геморрагические лихорадки - эволюция эпидемического потенциала. Журн. микробиол. 2002, 1: 91-98.
  3. Маркин В.А. Коллекции патогенных вирусов в решении общебиологических проблем. Журн. микробиол. 2007, 6: 84-93.
  4. Резапкин В.Г., Ткаченко Е.Н., Иванова А.П. Определение аренавирусных антигенов и антител методом твёрдофазного радиоиммунологического анализа. Вопр. вирусол. 1981, 4: 459-462.
  5. AHF vaccine example means to people. Vaccine Weekly. 1997, 14: 6-7.
  6. Albarino C.G., Ghiizinelli P.D., Posikvetal D.M. Molecular characterization of attenuated Junin virus strains. J. Gen. Virol. 1997, 78: 1605-1610.
  7. Avilla G.N.V. Argentine hemorrhagic fever: A biological markers. Intervirology. 1981, 2: 97-102.
  8. Borio L., Inglesby D., Peters C. et al. Hemorrhagic fever viruses as biological weapons. Medical and public health management. JAMA. 2002, 287: 2391-2405.
  9. Boxaca M., De Guerrero L.B. The occurrence of virus interferon and circulating antibodies in mice after experimental infection with Junin virus. Arch. Ges. Virusforch. 1973, 40: 10-20.
  10. Buckley S.M. Junin and Tacaribe viruses in HeLa cells. Am. J. Trop. Med. Hyg. 1965, 5: 792-794.
  11. Buggiero H.A. Treatment of Argentine hemorrhagic fever: Use of coalescent plasma and immunosuppressive drugs. Pren. Med. Argent. 1974, 61: 231-240.
  12. Candurra N.A., Damonte E.B., Coto C.E. Antigenic relationships between attenuated and pathogenic strains of Junin virus. J. Med. Virol. 1989, 2: 145-150.
  13. Candurra N.A., Damone E.B. Accion inhibitoria de la cafeina sorbe la multiplication del virus Junin. Rev. Argent. Microb. 1999, 3: 135-141.
  14. Calello M.A., Rabinovich R.D., Boxaca M.C. Relationship between Junin virus infection of thymus and establishment of persistence in rodents. Med. Microb. Immunol. 1986, 2-3: 92-95.
  15. Castilla V., Mersich S.E., Candurra N.A. The entry of Junin virus into Vero cells. Arch. Virol. 1994, 136: 363-374.
  16. Charrel R.N., Delamballerie X. Arenaviruses other then Lassa virus. Antivir. Res. 2003, 57: 89-100.
  17. Clegg J.C.S., Bowen M.D., Buchmeier M.J. et al. Virus Taxonomy. Seventh Report of the International Committee for the Taxonomy of Viruses. Academic Press, New York, 2000.
  18. Coto C.E. Junin virus. Progr. Med. Virol. 1974, 18: 127-142.
  19. DeBracco M.E., Rimoldi M.T. Argentine hemorrhagic fever. J. Med. 1970, 5: 216-221.
  20. DeGuerrero L.B., Boxaca M. Pathogenesis of attenuated Junin virus in the guinea pig model. J. Med. Virol. 1985, 2: 197-202.
  21. Enria D.A., Briggiler A.M., Levis S. et al. Tolerance and antiviral effect of ribavirin in patients with Argentine hemorrhagic fever. Antivir. Res. 1987, 7(6): 353-359.
  22. Enria D.A., Maiztegui J.I. Antiviral treatment of Argentine hemorrhagic fever. Antivir. Res. 1994, 23: 23-31.
  23. Garcia J.B., Morzunov S.P., Levis S. et al. Genetic diversity of the Junin virus in Argentina: Geographic and temporal patterns. Virology. 2000, 1: 127-136.
  24. Gonzales J.P., Lechuga M. Les arenavirus du noaveau monde: virus en evolution et melodies emergents. Med. Trop. 2000, 2: 42-49.
  25. Johnson K.M., Webb P.A. Biology of Tacaribe complex, virus LChM and other arenaviruses. Berlin, Springer Verlag, 1973.
  26. Kenyon R.H. Effect of immunosupression on experimental Argentine hemorrhagic fever in guinea pigs. J. Virol. 1985, 1: 75-80.
  27. Kenyon R.H., Canonico P.G., Grenn D.E. et al. Effect of ribavirin and trybutylribavirin on Argentine hemorrhagic fever (Junin virus) in guinea pigs. Antimicrob. Agents Chemother. 1986, 3: 521-523.
  28. Кenyon R.H., McKee K.T., Maiztequi D.E. et al. Heterogeneity of Junin virus strains. Med. Microbiol. Immunol. 1986, 175: 169-172.
  29. Krayetz F.Q., Percich R.E. Destruction of Junin virus and its reservoirs: A tool for Argentine hemorrhagic fever risk. Interscience. 1986, 42: 185-188.
  30. Laguens R.M., Avila M.A., Samoilovich S.R. et al. Pathogenicity of an attenuated strain (XJCl 3) of Junin virus. Intervirology. 1983, 4: 195-201.
  31. Lopez N., Rossi C. Homologous and heterologous glycoproteins induce protection against Junin virus challenge guinea pigs. J. Gen. Virol. 2000, 5: 1273-1281.
  32. Lozano M.E., Enria D., Maiztegui J.I. Rapid diagnosis of Argentine hemorrhagic fever by reverse transcriptase PCR-based assay. J. Clin. Microbiol. 1995, 5: 1327-1332.
  33. Maiztegui J.S., Fernandez N.J. Efficacy of immune plasma treatment of Argentine hemorrhagic fever and association between treatment and a late neurological syndrome. Lancet. 1979, 8415: 1216-1217.
  34. Maiztequi J.I., McKee J., Barrera J.G. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. J. Infect. Dis. 1998, 2: 277-283.
  35. Mettler N.E., Casals J. Susceptibility of mice aged 0-14 days to infection with Junin virus. Proc. Exp. Biol. Med. 1970: 4: 1051-1054.
  36. Mekeek J.R., Huggins J.W., Thrahen C.J. et al. Ribavirin prophylaxis and therapy of experimental Argentine hemorrhagic fever. Antimicrob. Agents Chemother. 1988, 9: 1304-1309.
  37. Morales M.A., Calderon G.E., Riera L.M. et al. Evaluation of an enzyme-linked immunosorbent assay for detection of antibodies to Junin virus in rodents. J. Virol. Meth. 2002, 1: 57-66.
  38. Parody A.S., Rugiero H.R., Greenway D.J. et al. Isolation of the Junin virus (epidemic hemorrhagic fever) from the mice of the epidemic area (Echinolaelaps echindinus, Barlese). Prensa. Med. Agent. 1959, 4: 2242-2244.
  39. Parody A.C. Sobre la etiologia del brote epidemica de Junin. Dia Med. 1968, 30: 2300-2302.
  40. Rebecca F. Maiztegui J. L'interferon endogene, facteur de manwais pronostic dans la fievre hemorragique argentine. Med. Sci. 1989, 8: 585-588.
  41. Remesar M.C., Blejer J.L., Weissenbacher M.C. Ribavirin effect on experimental Junin virus-induced encephalitis. J. Med. Virol. 1988, 1: 79-84.
  42. Ruggiero H.A. Argentine hemorrhagic fever: Early diagnosis by immunofluorescence. Arch. Virol. 1981, 2: 165-168.
  43. Vaccination against Argentine hemorrhagic fever. WER. 1993, 32: 233-234.
  44. Videla C., Carballal G., Remorini P. et al. Formalin inactivated Junin virus: Immunogenicity and protection assay. J. Med. Virol. 1989, 3: 215-220.
  45. Viral hemorrhagic fever: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis. CDC: 2004 CJDRAP/JDSA.
  46. Weissenbacher M.С, Sabatini M.S. Junin virus activity in two rural populations of the Argentine hemorrhagic fever endemic area. J. Med. Virol. 1983, 4: 273-280.
  47. Weissenbacher M.C., Calello M.A., Merani M.S. et al. Therapeutic effect of the antiviral agent ribavirin in Junin virus infection of primates. J. Med. Virol. 1986, 3: 261-267.
  48. Weissenbacher M.C., Avilla M.M., Calello M.A. et al. Effect of ribavirin and immune serum on Junin virus-infected primates. Microb. Immun. 1986, 175: 183-186.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2012 Markin V.A., Pantyukhov V.B., Markov V.I., Bondarev V.P., Markin V.A., Pantyukhov V.B., Markov V.I., Bondarev V.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies